BIOMAT Database Logo BIOMAT Database Logo

[Exon-intron structure and organization of the 5'-terminal region of the human p53 gene]. 1988

V L Bukhman, and P M Chumakov, and N N Ninkina, and B O Glotov, and G P Georgiev

S1 mapping and nucleotide sequencing were used for localization of exon-intron junctions of the human p53 gene. The 3'-end of the gene was localized 12 nucleotides downstream AATAAA sequence, though an mRNA, 94 nucleotides shorter, was observed in one tumor. No typical promoter sequences were found at the 5'-end of the gene. In cell-free HeLa extracts transcription of RNA initiates within the sequence of possible hairpin-loop structure. Organization of the promoter region of the human p53 gene is discussed.

UI MeSH Term Description Entries
D007438 Introns Sequences of DNA in the genes that are located between the EXONS. They are transcribed along with the exons but are removed from the primary gene transcript by RNA SPLICING to leave mature RNA. Some introns code for separate genes. Intervening Sequences,Sequences, Intervening,Intervening Sequence,Intron,Sequence, Intervening
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D009690 Nucleic Acid Conformation The spatial arrangement of the atoms of a nucleic acid or polynucleotide that results in its characteristic 3-dimensional shape. DNA Conformation,RNA Conformation,Conformation, DNA,Conformation, Nucleic Acid,Conformation, RNA,Conformations, DNA,Conformations, Nucleic Acid,Conformations, RNA,DNA Conformations,Nucleic Acid Conformations,RNA Conformations
D009857 Oncogenes Genes whose gain-of-function alterations lead to NEOPLASTIC CELL TRANSFORMATION. They include, for example, genes for activators or stimulators of CELL PROLIFERATION such as growth factors, growth factor receptors, protein kinases, signal transducers, nuclear phosphoproteins, and transcription factors. A prefix of "v-" before oncogene symbols indicates oncogenes captured and transmitted by RETROVIRUSES; the prefix "c-" before the gene symbol of an oncogene indicates it is the cellular homolog (PROTO-ONCOGENES) of a v-oncogene. Transforming Genes,Oncogene,Transforming Gene,Gene, Transforming,Genes, Transforming
D010750 Phosphoproteins Phosphoprotein
D011401 Promoter Regions, Genetic DNA sequences which are recognized (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes. rRNA Promoter,Early Promoters, Genetic,Late Promoters, Genetic,Middle Promoters, Genetic,Promoter Regions,Promoter, Genetic,Promotor Regions,Promotor, Genetic,Pseudopromoter, Genetic,Early Promoter, Genetic,Genetic Late Promoter,Genetic Middle Promoters,Genetic Promoter,Genetic Promoter Region,Genetic Promoter Regions,Genetic Promoters,Genetic Promotor,Genetic Promotors,Genetic Pseudopromoter,Genetic Pseudopromoters,Late Promoter, Genetic,Middle Promoter, Genetic,Promoter Region,Promoter Region, Genetic,Promoter, Genetic Early,Promoter, rRNA,Promoters, Genetic,Promoters, Genetic Middle,Promoters, rRNA,Promotor Region,Promotors, Genetic,Pseudopromoters, Genetic,Region, Genetic Promoter,Region, Promoter,Region, Promotor,Regions, Genetic Promoter,Regions, Promoter,Regions, Promotor,rRNA Promoters
D004720 Endonucleases Enzymes that catalyze the hydrolysis of the internal bonds and thereby the formation of polynucleotides or oligonucleotides from ribo- or deoxyribonucleotide chains. EC 3.1.-. Endonuclease
D005091 Exons The parts of a transcript of a split GENE remaining after the INTRONS are removed. They are spliced together to become a MESSENGER RNA or other functional RNA. Mini-Exon,Exon,Mini Exon,Mini-Exons
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

V L Bukhman, and P M Chumakov, and N N Ninkina, and B O Glotov, and G P Georgiev
Exon-intron organization of the human 5-HT3A receptor gene.
January 2000, Neuropharmacology,
V L Bukhman, and P M Chumakov, and N N Ninkina, and B O Glotov, and G P Georgiev
Characterization of human Fas gene. Exon/intron organization and promoter region.
February 1995, Journal of immunology (Baltimore, Md. : 1950),
V L Bukhman, and P M Chumakov, and N N Ninkina, and B O Glotov, and G P Georgiev
Human interferon regulatory factor 2 gene. Intron-exon organization and functional analysis of 5'-flanking region.
February 1994, The Journal of biological chemistry,
V L Bukhman, and P M Chumakov, and N N Ninkina, and B O Glotov, and G P Georgiev
Genomic organization of the human thyroglobulin gene: the complete intron-exon structure.
October 2001, European journal of endocrinology,
V L Bukhman, and P M Chumakov, and N N Ninkina, and B O Glotov, and G P Georgiev
Exon-intron organization of the human dystrophin gene.
October 1997, Genomics,
V L Bukhman, and P M Chumakov, and N N Ninkina, and B O Glotov, and G P Georgiev
Exon-intron organization of the human gp130 gene.
February 2000, Gene,
V L Bukhman, and P M Chumakov, and N N Ninkina, and B O Glotov, and G P Georgiev
Characterization of the human blood coagulation factor XII gene. Intron/exon gene organization and analysis of the 5'-flanking region.
October 1987, The Journal of biological chemistry,
V L Bukhman, and P M Chumakov, and N N Ninkina, and B O Glotov, and G P Georgiev
The exon-intron structure of human LHX1 gene.
December 1996, Biochemical and biophysical research communications,
V L Bukhman, and P M Chumakov, and N N Ninkina, and B O Glotov, and G P Georgiev
The human CILP gene: exon/intron organization and chromosomal mapping.
October 1999, Matrix biology : journal of the International Society for Matrix Biology,
V L Bukhman, and P M Chumakov, and N N Ninkina, and B O Glotov, and G P Georgiev
Structure of the human aggrecan gene: exon-intron organization and association with the protein domains.
July 1995, The Biochemical journal,
Copied contents to your clipboard!